A Pivotal Multicenter Trial of Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia

SUMMARY

N/A

COH Protocol Number : 14326

ClinicalTrials.gov Number : NCT01829711

Principal Investigator : Siddiqi, Tanya M.D.

Sponsor : MedImmune, LLC

BRIEF ELIGIBILITY CRITERIA :

Eligible Ages : >=18

Gender : Either

Minimum Performance Status : ECOG/SWOG:0

Treatment Intent : Non-Adjuvant treatment

Prior Chemotherapy :

Brain Metastases :

Measurable Disease :